These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21400258)

  • 1. Sacral neuromodulation in patients with multiple sclerosis.
    Minardi D; Muzzonigro G
    World J Urol; 2012 Feb; 30(1):123-8. PubMed ID: 21400258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction.
    Andretta E; Simeone C; Ostardo E; Pastorello M; Zuliani C
    J Neurol Sci; 2014 Dec; 347(1-2):257-61. PubMed ID: 25454644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.
    Aboseif S; Tamaddon K; Chalfin S; Freedman S; Kaptein J
    Urology; 2002 Jul; 60(1):52-6. PubMed ID: 12100921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation for lower urinary tract dysfunction.
    Van Kerrebroeck PE; Marcelissen TA
    World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
    Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S
    Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation and lower urinary tract dysfunction in cerebral palsy.
    Roth TM
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 May; 18(5):567-9. PubMed ID: 16804635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes of the ARTISAN-SNM study with the Axonics System for the treatment of urinary urgency incontinence.
    Benson K; McCrery R; Taylor C; Padron O; Blok B; de Wachter S; Pezzella A; Gruenenfelder J; Pakzad M; Perrouin-Verbe MA; Van Kerrebroeck P; Mangel J; Peters K; Kennelly M; Shapiro A; Lee U; Comiter C; Mueller M; Goldman H; Lane F
    Neurourol Urodyn; 2020 Jun; 39(5):1482-1488. PubMed ID: 32339339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study.
    van Kerrebroeck PE; van Voskuilen AC; Heesakkers JP; Lycklama á Nijholt AA; Siegel S; Jonas U; Fowler CJ; Fall M; Gajewski JB; Hassouna MM; Cappellano F; Elhilali MM; Milam DF; Das AK; Dijkema HE; van den Hombergh U
    J Urol; 2007 Nov; 178(5):2029-34. PubMed ID: 17869298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
    Daniels DH; Powell CR; Braasch MR; Kreder KJ
    Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
    Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
    BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral nerve stimulation for neuromodulation of the lower urinary tract.
    Hubsher CP; Jansen R; Riggs DR; Jackson BJ; Zaslau S
    Can J Urol; 2012 Oct; 19(5):6480-4. PubMed ID: 23040633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of Sacral Neuromodulation in Patients With Underlying Neurologic Lower Urinary Tract Dysfunction and Fecal Incontinence.
    Schwarztuch Gildor O; Neheman A; Vainrib M
    Urology; 2024 Jun; 188():54-62. PubMed ID: 38417466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
    Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.
    Puccini F; Bhide A; Elneil S; Digesu GA
    Int Urogynecol J; 2016 Mar; 27(3):347-54. PubMed ID: 26156206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.